GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in therapeutic research, largely due to its notable impact on treating diseases such as type 2 diabetes and obesity. Ongoing research have shown that beyond glucose control, GLP-1 medications of